Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1960 1
1965 1
1969 1
1972 1
1979 1
1984 3
1986 3
1987 1
1988 4
1989 5
1990 2
1991 1
1992 3
1993 3
1994 3
1995 2
1996 3
1997 2
1998 2
1999 1
2000 2
2001 6
2002 5
2003 9
2004 4
2005 10
2006 7
2007 9
2008 10
2009 5
2010 12
2011 8
2012 7
2013 10
2014 8
2015 9
2016 11
2017 10
2018 20
2019 11
2020 14
2021 11
2022 14
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
Reich K, Papp KA, Blauvelt A, Tyring SK, Sinclair R, Thaçi D, Nograles K, Mehta A, Cichanowitz N, Li Q, Liu K, La Rosa C, Green S, Kimball AB. Reich K, et al. Among authors: la rosa c. Lancet. 2017 Jul 15;390(10091):276-288. doi: 10.1016/S0140-6736(17)31279-5. Epub 2017 Jun 6. Lancet. 2017. PMID: 28596043 Clinical Trial.
Searching for alternatives to brain regeneration.
La Rosa C, Bonfanti L. La Rosa C, et al. Neural Regen Res. 2021 Nov;16(11):2198-2200. doi: 10.4103/1673-5374.310683. Neural Regen Res. 2021. PMID: 33818492 Free PMC article. No abstract available.
The role of microRNAs in thyroid carcinomas.
Forte S, La Rosa C, Pecce V, Rosignolo F, Memeo L. Forte S, et al. Among authors: la rosa c. Anticancer Res. 2015 Apr;35(4):2037-47. Anticancer Res. 2015. PMID: 25862858 Review.
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.
Birring SS, Dicpinigaitis PV, Smith JA, Morice AH, McGarvey LP, Pavord ID, Nguyen AM, Schelfhout J, Li Q, Iskold B, Green SA, Philip G, Muccino DR, La Rosa C. Birring SS, et al. Among authors: la rosa c. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1539-1542. doi: 10.1164/rccm.202211-2128LE. Am J Respir Crit Care Med. 2023. PMID: 36996347 Free PMC article. No abstract available.
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.
Smith JA, Birring SS, Dicpinigaitis PV, McGarvey LP, Morice AH, Pavord ID, Satia I, Green S, Iskold B, La Rosa C, Li Q, Martin Nguyen A, Schelfhout J, Muccino D. Smith JA, et al. Among authors: la rosa c. Lung. 2022 Aug;200(4):423-429. doi: 10.1007/s00408-022-00553-y. Epub 2022 Jul 27. Lung. 2022. PMID: 35895098 Free PMC article. Clinical Trial.
Laser treatment of medical skin disease in women.
LaRosa C, Chiaravalloti A, Jinna S, Berger W, Finch J. LaRosa C, et al. Int J Womens Dermatol. 2017 Jul 21;3(3):131-139. doi: 10.1016/j.ijwd.2017.05.002. eCollection 2017 Sep. Int J Womens Dermatol. 2017. PMID: 28831422 Free PMC article. Review.
256 results